Neural Predictors of Antidepressant Treatment Response to Quetiapine XR and Citalopram in Major Depressive Disorder

被引：0
|
作者：
Burgess, Ashley [1 ]
White, Richard [1 ]
Cortese, Fil [2 ]
Goodyear, Bradley [2 ]
Panicker, Aaron [1 ]
Karnes, Amanda [1 ]
Roy, Kamalika [1 ]
Diwadkar, Vaibhav A. [1 ]
Ramasubbu, Raj [2 ]
机构：
[1] Wayne State Univ, Sch Med, Dept Psychiat & Behav Neurosci, Detroit, MI USA
[2] Univ Calgary, Sch Med, Dept Psychiat & Clin NeuroSci, Calgary, AB, Canada
来源：
BIOLOGICAL PSYCHIATRY | 2013年 / 73卷 / 09期
关键词：
Major Depressive Disorder; Neural Predictor; antidepressant treatment;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
185
引用
收藏
页码：60S / 60S
页数：1
相关论文
共 50 条
  • [1] Quetiapine XR: Current status for the treatment of major depressive disorder
    Pae, Chi-Un
    Sohi, Manmohandeep Singh
    Seo, Ho-Jun
    Serretti, Alessandro
    Patkar, Ashwin A.
    Steffens, David C.
    Masand, Prakash S.
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2010, 34 (07): : 1165 - 1173
  • [2] Neural Correlates of Antidepressant Treatment Response in Adolescents with Major Depressive Disorder
    Cullen, Kathryn R.
    Klimes-Dougan, Bonnie
    Dung Pham Vu
    Schreiner, Melinda Westlund
    Mueller, Bryon A.
    Eberly, Lynn E.
    Camchong, Jazmin
    Westervelt, Ana
    Lim, Kelvin O.
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2016, 26 (08) : 705 - 712
  • [3] Pharmacogenomic predictors of citalopram treatment outcome in major depressive disorder
    Mamdani, Firoza
    Berlim, Marcelo T.
    Beaulieu, Marie-Martine
    Turecki, Gustavo
    [J]. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2014, 15 (02): : 135 - 144
  • [4] Quetiapine XR monotherapy and quetiapine XR plus ongoing antidepressant versus lithium plus ongoing AD for Stage II treatment-resistant major depressive disorder
    Franco Martin, M.
    Figueira, M. L.
    Petrov, P.
    Rihmer, Z.
    Vavrusova, L.
    Dencker-Vansvik, E.
    Jorgensen, L.
    Koehler, J.
    Bauer, M.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S347 - S347
  • [5] Extended release Quetiapine Fumarate (Quetiapine XR) monotherapy in the treatment of patients with major depressive disorder (MDD)
    Montgomery, S.
    Cutler, A.
    Lazarus, A.
    Schollin, M.
    Brecher, M.
    [J]. EUROPEAN PSYCHIATRY, 2008, 23 : S259 - S260
  • [6] Neural Markers of Early Treatment Response During Antidepressant Treatment in Major Depressive Disorder
    Ramasubbu, Rajamannar
    Goodyear, Bradley
    Gaxiola, Ismael
    MacQueen, Glenda
    [J]. BIOLOGICAL PSYCHIATRY, 2010, 67 (09) : 145S - 145S
  • [7] Antidepressant effects of citalopram on treatment of alopecia areata in patients with major depressive disorder
    Abedini, Hossein
    Farshi, Susan
    Mirabzadeh, Arash
    Keshavarz, Saeed
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2014, 25 (02) : 153 - 155
  • [8] Efficacy of quetiapine extended release in major depressive disorder without optimal clinical response to antidepressant treatment
    Romero Guillena, S. L.
    Aguilar Valseca, P.
    Plasencia Garcia de Diego, B.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S252 - S252
  • [9] Inadequate Response to Antidepressant Treatment in Major Depressive Disorder
    Papakostas, George I.
    Jackson, W. Clay
    Rafeyan, Roueen
    Trivedi, Madhukar H.
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2020, 81 (03)
  • [10] Once-daily extended release quetiapine fumarate (quetiapine XR) as adjunct to) antidepressant therapy fit patients with major depressive disorder
    Constant, E.
    Pretorius, H. W.
    Earley, W.
    Lindgren, P.
    Brecher, M.
    Bauer, M.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 184 - 184
12345